Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Pancreas. 2013 Nov;42(8):10.1097/MPA.0b013e3182a23ae4. doi: 10.1097/MPA.0b013e3182a23ae4

Figure 2. Publication trend for biomarker studies that examined the expression of molecular markers involved in gemcitabine metabolism.

Figure 2

Publication summary of gemcitabine metabolism biomarker studies. Bar graph represents the percent distribution of each biomarker examined & reported on survival in these 21 studies. Stacked color bars represent the distribution of the index assays employed (BLUE bar: immunohistochemistry; YELLOW bar: gene-expression quantitative assay). Line graph represents the total number of patients samples (per 100) evaluated for each biomarker (solid line: adjuvant and neoadjuvant settings combined; dashed line: palliative setting).